Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark

arXiv 2026 37.7 method

TLDR

Introduces NMO Benchmark for nanotechnology molecular optimization using quantum simulations, revealing simple methods outperform advanced ones.

Reasoning

Strengths include addressing domain transfer limitations and using physics-based tasks with surprising results. Weaknesses are reliance on simulations without real-world validation and narrow focus on molecular optimization.

Read-first score

Read-first score 37.7, weighted from topical fit, citation, graph, method, reproducibility, and recency signals. Original total remains 7.

Recency 8%

100

Uses a gentle age decay so recent papers surface without erasing older foundations. 2026

Methodology quality 25%

Screens visible abstract and analysis fields for experiment, dataset, baseline, metric, and limitation evidence. markers=baseline,benchmark,dataset,metric,result

Reproducibility 25%

Screens links and visible text for paper, code, dataset, artifact, and repository signals. pdf=True; code=False; dataset=False; markers=dataset

Topical relevance 42%

5.8

Uses existing LLM keyword relevance scores normalized to 0-100. AI scientist,automated scientific discovery,autonomous research agent,automated research,literature review agent,survey generation,automated experimentation,experiment design agent,AI for scientific research,paper writing agent,research automation,scientific discovery agent

Field roles

FrontierMethodology anchor

Rank sensitivity

Stability: volatile; rank range: 24.

Keyword Scores

AI for scientific research

automated scientific discovery

automated research

research automation

AI scientist

autonomous research agent

literature review agent

survey generation

automated experimentation

experiment design agent

paper writing agent

scientific discovery agent

Resources

Paper